Corcept is leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators. In 2012, we received FDA approval of Korlym® (mifepristone), the first approved treatment for hypercortisolism (Cushing’s syndrome). Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation. What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease. We are seeking a highly analytical and results-oriented Senior Manager or Associate Director, Commercial Analytics to join our Endocrinology division. This hands-on, high-visibility role will analysis and insight delivery that inform commercial strategy across payer analytics, specialty pharmacy performance, real-world evidence (RWE), and market research. The ideal candidate thrives in a fast-paced, collaborative environment, and is equally adept at leading market research initiatives, interrogating syndicated data sources, and communicating clear, data-driven narratives to senior leadership. You’ll balance tactical analytical execution with strategic business impact, working cross-functionally to translate complex insights into actionable recommendations. While you’ll collaborate with external data vendors and consultants, you’ll retain ownership of the analysis, synthesis, and delivery of insights that drive commercial performance and strategy.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Number of Employees
251-500 employees